Dr. Noor Abuhadra discusses managing adverse events in patients receiving TRODELVY (sacituzumab govitecan), a later-line systemic therapy for metastatic triple-negative breast cancer. Shay Elkins, a patient, shares her experience with significant side effects including diarrhea, low white blood cell counts, and hair loss, while Dr. Abuhadra emphasizes the need for proactive management of these issues to maximize treatment time and maintain quality of life.
The production of the Covid-19 vaccine, Covaxin, will soon begin at Uttar Pradesh s Bulandshahr. Covaxin is an indigenous vaccine being manufactured by Hyderabad-based biotechnology company, Bharat Biotech.
All geared up to start making vaccine immediately: BIBCOL
April 19, 2021
Under Mission Covid Suraksha, the government roped in other vaccine makers to accelerate production of indigenous Covid-19 vaccines - Getty Images/iStockphoto
Under Mission Covid Suraksha, the government roped in other vaccine makers to accelerate production of indigenous Covid-19 vaccines - Getty Images/iStockphoto×
Company has huge spare capacity at its existing oral polio vaccine plant Government-owned polio vaccine maker, Bharat Immunologicals & Biologicals Corporation Limited (BIBCOL) is geared up to manufacture India’s indigenous Covid-19 vaccine with its existing spare capacity. Senior company officials informed that once cleared from the Centre, BIBCOL can start production “immediately.”